The American Kidney Fund released its fourth annual report card ranking states' support of living organ donation. Researchers studied the association between adolescent BMI and early CKD in young adulthood. The FDA has granted a Humanitarian Device Exemption Approval Order to the Selective Cytopheretic Device Pediatric. Nutrition therapy may help manage the uremic complications associated with cardiovascular risk in those with kidney failure. Potential living kidney donors may be unprepared for possible negative outcomes following donation. Anemia associated with CKD can be treated with oral hypoxia-inducible factor prolyl hydroxylase inhibitors. Patients hospitalized with COVID-19 face increased risk for long-term adverse outcomes such as major adverse kidney events. Patients receiving maintenance dialysis have high rates of hospitalization and admission to nursing homes. The benefit-risk ratio and considerations about unmet need are worth considering. There was no association between kidneys from active COVID-19-positive donors procured in 2023 and higher odds of nonuse. Unilateral nephrectomy resulted in a decrease of 46.4% in urinary EGF excretion, and a decrease of 35.2% in eGFR. Patients with diabetic kidney disease face increased risk of end-stage kidney disease and dialysis. Serum creatinine-based eGFR (eGFRcr) remains inaccurate and can overestimate eGFR, particularly in patients with sarcopenia. Patients with autosomal dominant polycystic kidney disease commonly progress to ESRD in the fifth decade of life. Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the accumulation of fluid-filled cysts in the kidney The choice of a billing solution, often made under the guise of cost savings, requires a thoughtful approach. Albuminuria, hypertension, declining kidney function, and an increase in cardiovascular risk are all hallmarks of DKD. Strategies for the accurate evaluation of the risk of fragility fractures in elderly patients in the early stages of DKD. Metformin users had a lower risk of graft failure, even after accounting for the competing risk of all-cause mortality. The total intervention consisted of 12 meetings, with a mean duration of 89 minutes.